Cytochroma
PrivateLast Round
Accelerator
Sep 15, 2025
Total Funding Raised
$1.64M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cytochroma is a biotechnology company that provides genetically diverse, iPSC-derived cell models and screening services to predict drug safety and efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytochroma Comparables
Compare Cytochroma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xellar Biosystems | 84% | |
| Curi Bio | 81% | |
| Hesperos Inc. | 79% | |
Cytochroma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 15, 2025 | ||||
| Early Funding | Oct 17, 2024 | ||||
| Seed | Dec 16, 2021 |
Cytochroma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investing Women Angels | Seed, Early Funding |
| Angel Academe | Seed |
| Morgan Stanley Inclusive & Sustainable Ventures | Accelerator |
| Cambridge Capital Group | Seed |
| Innovate UK | Seed |
| Scottish Investment Bank (Scottish Enterprise) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2025
$340K round led by Morgan Stanley Inclusive & Sustainable Ventures
- Oct 17, 2024
Received investment from Investing Women Angels.
Cytochroma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytochroma's valuation, stock price, and market status.